NCT01456416View on ClinicalTrials.gov

Glatiramer Acetate for Multiple Sclerosis With Autoimmune Comorbidities

CompletedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Relapsing Remitting Multiple Sclerosis
Trial Locations (1)

90033

USC MS Comprehensive Care Center & Research Group, Los Angeles

All Listed Sponsors
collaborator

Teva Pharmaceuticals USA

INDUSTRY

lead

University of Southern California

OTHER

NCT01456416 - Glatiramer Acetate for Multiple Sclerosis With Autoimmune Comorbidities | Biotech Hunter | Biotech Hunter